ClinicalTrials.gg
Not yet recruitingNCT07823868FSHRCD: RCTUpdated Sep 22, 2026

Frankincense Versus Sodium Hypochlorite for Root Canal Disinfection

An Early Phase 1 interventional study of Sodium hypochlorite 3% and Frankincense-based irrigant in Pulp Necrosis, Root Canal Infection and Apical Periodontitis, sponsored by Oman Dental College. Not yet recruiting at 1 site in Oman. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Oman Dental College · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This research study is being done to find out if a natural ingredient called frankincense can clean infected root canals as effectively as the standard cleaning solution currently used in dentistry.

When a tooth's nerve dies from infection, dentists use a strong cleaning liquid, called sodium hypochlorite, to kill bacteria inside the tooth before filling it. This liquid works well, but it can sometimes irritate the gums or taste unpleasant. Frankincense, a natural substance long used in Oman, has shown early signs in laboratory studies that it may also fight bacteria effectively, with fewer side effects.

In this study, patients needing root canal treatment for an infected, dead tooth will be randomly placed into one of two groups. One group will have their tooth cleaned with the standard liquid. The other group will have their tooth cleaned with the frankincense-based liquid. Before and after cleaning, a small, painless sample will be taken from inside the tooth to measure how much bacteria is present, using a lab test called PCR. The results from both groups will then be compared to see which cleaning liquid removes more bacteria.

Patients who are between 18 and 50 years old, and who need root canal treatment for a dead/infected tooth, may be able to join. The study involves no extra visits beyond normal root canal treatment.

Read the detailed description

This is a single-center, randomized, active-controlled clinical trial evaluating a standardized frankincense-based intracanal irrigant compared with 3% sodium hypochlorite (NaOCl) in patients with pulpal necrosis, conducted at Oman Dental College.

Eligible participants are adults aged 18-50 years diagnosed with pulpal necrosis (single- or multi-rooted teeth), with or without apical periodontitis. Exclusion criteria include periodontal pockets greater than 4 mm, calcified canals, acute apical abscess, internal resorption, open apex, retreatment cases, antibiotic therapy within the prior 3 months, pregnancy, and systemic comorbidities.

Thirty root canals will be enrolled and allocated 1:1 to two groups using block randomization: Group A (control) will receive standard 3% NaOCl, and Group B (intervention) will receive a standardized frankincense-based irrigant. Both irrigants will be delivered using the same standardized volume (approximately 5 mL) and activation time (30-60 seconds) to ensure the only planned difference between groups is the irrigant itself.

A pre-irrigation microbial sample will be collected from each canal using a sterile paper point, followed by irrigation with the assigned solution, and then a post-irrigation sample. Samples will be analyzed by quantitative real-time PCR (qPCR) for total bacterial load (universal 16S rRNA) and for Enterococcus faecalis specifically. Laboratory personnel performing the qPCR analysis, and the statistician analyzing the data, will be blinded to group allocation using coded sample identifiers.

The primary outcome is the log10 reduction in total bacterial load from pre- to post-irrigation. Secondary outcomes include the percentage reduction in bacterial load between groups, the reduction in E. faecalis counts, and adverse events (e.g., tissue irritation, discomfort). Statistical analysis will use paired t-tests or Wilcoxon signed-rank tests for within-group comparisons, and independent t-tests or Mann-Whitney U tests for between-group comparisons, with significance set at p\<0.05

02

Conditions studied

  • Pulp Necrosis
  • Root Canal Infection
  • Apical Periodontitis

Keywords

  • randomized control trial
  • Frankinscence endoodontic irrigant
03

In context

Dental Pulp Necrosis

156 studies on the registry are indexed under Dental Pulp Necrosis; 43 are open to participants now.

This study's planned enrollment of 30 is below the median of 45 across 147 interventional studies indexed under Dental Pulp Necrosis.

Browse Dental Pulp Necrosis studies →

Lead sponsor

Oman Dental College is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-50 years
  • Diagnosis of pulpal necrosis (single- or multi-rooted tooth), with or without apical periodontitis
  • Tooth suitable for standard endodontic access and microbiological sampling

Exclusion criteria

Exclusion Criteria:

  • Periodontal pockets >4 mm
  • Calcified canals
  • Acute apical abscess
  • Internal resorption
  • Open apex
  • Retreatment cases
  • Antibiotic/ herbal therapy within the prior 3 months
  • Pregnancy
  • Systemic comorbidities
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    3% Sodium Hypochlorite (Control)

    Participants randomized to this arm will receive standard 3% sodium hypochlorite (NaOCl) irrigation, the clinic's current standard-of-care irrigant, prepared according to institutional protocol. Approximately 5 mL of irrigant will be delivered per canal, with 30-60 seconds of activation (manual dynamic or sonic agitation), following standardized access, minimal instrumentation, and pre-irrigation microbiological sampling. A post-irrigation sample will be taken via sterile paper point immediately after irrigation.

    Drug: Sodium hypochlorite 3%

  • Experimental
    Frankincense-Based Herbal Irrigant (Intervention)

    Participants randomized to this arm will receive a standardized frankincense-based irrigant (Boswellia sacra-derived extract), formulated at a fixed concentration and pH, with batch sterility and endotoxin testing and stability/compatibility testing completed prior to clinical use. Approximately 5 mL of irrigant will be delivered per canal, with 30-60 seconds of activation (manual dynamic or sonic agitation, final protocol to be fixed prior to trial start), using the same standardized volume, activation method, and contact time as the control arm, following standardized access, minimal instrumentation, and pre-irrigation microbiological sampling. A post-irrigation sample will be taken via sterile paper point immediately after irrigation.

    Drug: Frankincense-based irrigant

Interventions

  • Standard-of-care root canal irrigant used as the active comparator. A 3% aqueous sodium hypochlorite solution, prepared per institutional protocol, delivered at approximately 5 mL per canal with 30-60 seconds of activation (manual dynamic or sonic agitation).

    Also known as: NaOCl 3%

  • DrugFrankincense-based irrigant

    Investigational root canal irrigant consisting of a standardized Boswellia sacra (frankincense) extract formulation, adjusted to a fixed concentration and pH, with batch sterility and endotoxin testing and stability/compatibility testing completed prior to clinical use. Delivered at approximately 5 mL per canal with 30-60 seconds of activation (manual dynamic or sonic agitation), matching the control arm's volume, activation method, and contact time so that the irrigant itself is the only planned difference between groups.

06

What researchers measure

Primary outcomes

  1. Reduction in Total Bacterial Load

    The change in total endodontic bacterial load, measured by quantitative real-time PCR (qPCR) targeting the universal 16S rRNA gene, calculated as log10(pre-irrigation bacterial load) minus log10(post-irrigation bacterial load). Assessed and compared between the frankincense-based irrigant group and the 3% NaOCl group.

    Time frame: 1 hour. First sample will be taken pre-intervention/procedural (before chemo-mechanical preparation) and the second sample will be taken immediately after the intervention (after completion of chemo-mechanical preparation) in the same clinical visit.

  2. Percentage Reduction in Total Bacterial Load Between Groups

    Comparison of the percentage reduction in total bacterial load (16S rRNA qPCR) between the frankincense-based irrigant group and the 3% NaOCl group. Time Frame: Within a single clinical visit; pre- to post-irrigation

    Time frame: This can be also referred to as Pre-procedural and post-procedural; the procedure being pulp extirpation followed by irrigation, cleaning and shaping of the rootcanals, within a single clinical visit; 1 hour. Pre-intervention & post-intervention samples

07

Study locations

1 site
  • Oman dental college
    Muscat, 111, Oman
08

References and documents

Publications

  • Gutmann JL, Manjarres V. Historical and Contemporary Perspectives on the Microbiological Aspects of Endodontics. Dent J (Basel). 2018 Sep 22;6(4):49. doi: 10.3390/dj6040049. PubMed 30249009 ↗
  • Palwankar D, Garg A, Tandan M, Bhasin P, Sachdeva A, Palwankar P. Antimicrobial efficacy of two commercially available herbal products with and without ultrasonic activation in primary endodontic infections: A randomized clinical trial. J Conserv Dent Endod. 2024 Mar;27(3):305-309. doi: 10.4103/JCDE.JCDE_308_23. Epub 2024 Mar 6. PubMed 38634027 ↗
  • Das A, et al. Comparative evaluation of herbal irrigants on root canal microflora: a clinical study. J Conserv Dent. 2024;27(2):120-126.
  • Almohareb RA, et al. Antibacterial efficacy of frankincense extract against Enterococcus faecalis: an in vitro study. Saudi Dent J. 2025;37(1):45-52.
  • Di Stefano M, et al. Chemical composition and antimicrobial activity of Boswellia sacra essential oils. Microorganisms. 2020;8(6):984.
  • Abushouk S, Lundy F, Linden G, Abdel Hamid MM, Ibrahim Y, El Karim I. Quantitative Analysis of Candidate Endodontic Pathogens and Their Association with Cause and Symptoms of Apical Periodontitis in a Sudanese Population. Eur Endod J. 2021 Apr;6(1):50-55. doi: 10.14744/eej.2020.52297. Epub 2021 Mar 3. PubMed 33762533 ↗
  • Zhang D, Shen Y, de la Fuente-Nunez C, Haapasalo M. In vitro evaluation by quantitative real-time PCR and culturing of the effectiveness of disinfection of multispecies biofilms in root canals by two irrigation systems. Clin Oral Investig. 2019 Feb;23(2):913-920. doi: 10.1007/s00784-018-2515-x. Epub 2018 Jun 15. PubMed 29948281 ↗
  • Swimberghe RCD, Coenye T, De Moor RJG, Meire MA. Biofilm model systems for root canal disinfection: a literature review. Int Endod J. 2019 May;52(5):604-628. doi: 10.1111/iej.13050. Epub 2018 Dec 20. PubMed 30488449 ↗
  • Siqueira JF Jr, Rocas IN. Present status and future directions: Microbiology of endodontic infections. Int Endod J. 2022 May;55 Suppl 3:512-530. doi: 10.1111/iej.13677. Epub 2022 Jan 13. PubMed 34958494 ↗
  • Cai C, Chen X, Li Y, Jiang Q. Advances in the Role of Sodium Hypochlorite Irrigant in Chemical Preparation of Root Canal Treatment. Biomed Res Int. 2023 Jan 13;2023:8858283. doi: 10.1155/2023/8858283. eCollection 2023. PubMed 36685672 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Data privacy of the patients. Patient data privacy is essential in dentistry to protect sensitive personal and medical information from unauthorized access or misuse. Dental professionals handle records such as medical histories, treatment plans, and personal details, making confidentiality a key responsibility. Information should only be accessed by authorized staff and shared only with patient consent or legal obligation. With digital records, strong security measures are vital, including encryption, secure systems, and controlled access. Regular staff training helps prevent data breaches and accidental disclosure. Legal frameworks such as HIPAA and GDPR ensure that patient information is handled responsibly and securely.Patients also have rights to access, review, and request corrections to their data, promoting transparency and trust. Overall, maintaining data privacy ensures ethical practice and strengthens patient confidence in us.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2027; primary completion for Dec 2027, 10 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 31, 2026
First posted
Sep 16, 2026
StartEst.
Jan 19, 2027
Primary completionEst.
Dec 7, 2027
CompletionEst.
May 7, 2028
Last update
Sep 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07823868
Lead sponsor
Oman Dental College
Collaborators
IMU University, Malaysia, Sultan Qaboos University
Responsible party
Sponsor
First posted
Sep 16, 2026
Start date
Jan 19, 2027 (estimated)
Primary completion
Dec 7, 2027 (estimated)
Completion
May 7, 2028 (estimated)
Last update
Sep 22, 2026

Study contacts

Triveni Mohan Nalawade, PhD
Contact
tnalawade@staff.odc.edu.om
91990834
Ayida Al Wahaibi, PhD
Contact
aalwohaibi@Staff.odc.edu.om
24665555 ext. 553
Triveni Mohan Nalawade
principal investigator · Oman Dental College

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion